COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01896999
Brief Title: Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
First Submitted : July 8, 2013
First Submitted that Met QC Criteria : July 8, 2013
First Posted : July 11, 2013 (Estimate)
Last Update Submitted that Met QC Criteria : January 20, 2021
Last Update Posted : January 22, 2021